Descrizione

Relapse rates in ulcerative colitis patients maintained on curcumin therapy are tracked over follow-up periods. Curcumin-supplemented groups demonstrated lower relapse rates compared to standard therapy alone.

Figure 13

Chart

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 13: Relapse rates in ulcerative colitis patients maintained on curcumin therapy are tracked over follow-up periods. Curcumin-supplemented groups demonstrated lower relapse rates compared to standard therapy alone.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Relapse rates in ulcerative colitis patients maintained on curcumin therapy are tracked over follow-up periods. Curcumin-supplemented groups demonstrated lower relapse rates compared to standard therapy alone." />
  <figcaption>Figure 13. Relapse rates in ulcerative colitis patients maintained on curcumin therapy are tracked over follow-up periods. Curcumin-supplemented groups demonstrated lower relapse rates compared to standard therapy alone.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

Evidenze correlate

Curcumin per Ulcerative Colitis (UC)

Grado B · 5 studi

Curcumin per Crohn's Disease

Grado C · 3 studi